July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine’s (JNM) July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 (18F) labeled ligand is a promising approach for diagnostic imaging.
FDA Releases Preliminary Findings From Ongoing CardioGen-82 Investigations
Trend Toward Personalized Medicine May Uplift Nuclear Imaging Market
Radio Tracer Grows at Rapid Rate
Home Imaging Technology News
Heart Hospital: A League of Their Own
Study on Novel Cardiac PET Tracer Launches
Lantheus to Study Safety of Novel PET Agent for Heart Failure
Trends in Cardiac Nuclear Imaging
Radiopharmaceuticals and Tracers